{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:55:29Z","timestamp":1791593729523,"version":"4.3.4"},"reference-count":381,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T00:00:00Z","timestamp":1649289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"St Vincent\u2019s Hospital (Melbourne) Research Endowment Fund"},{"name":"Stafford Fox Medical Research Foundation"},{"name":"St Vincent\u2019s Institute Rising Star Award"},{"name":"Victorian Government (Australia) Operational Infrastructure"},{"name":"St Vincent\u2019s Institute of Medical Research"},{"name":"Duke-NUS Signature Research Programme"},{"name":"Ministry of Health, Singapore Ministry of Health\u2019s National Medical Research Council","award":["NMRC\/CSA-SI\/0011\/2017"],"award-info":[{"award-number":["NMRC\/CSA-SI\/0011\/2017"]}]},{"name":"Ministry of Health, Singapore Ministry of Health\u2019s National Medical Research Council","award":["CGAug16M006"],"award-info":[{"award-number":["CGAug16M006"]}]},{"name":"Ministry of Health, Singapore Ministry of Health\u2019s National Medical Research Council","award":["NMRC\/CGAug16C006"],"award-info":[{"award-number":["NMRC\/CGAug16C006"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,5,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Patients with Type 2 diabetes mellitus (T2DM) frequently exhibit a distinctive cardiac phenotype known as diabetic cardiomyopathy. Cardiac complications associated with T2DM include cardiac inflammation, hypertrophy, fibrosis, and diastolic dysfunction in the early stages of the disease, which can progress to systolic dysfunction and heart failure. Effective therapeutic options for diabetic cardiomyopathy are limited and often have conflicting results. The lack of effective treatments for diabetic cardiomyopathy is due in part, to our poor understanding of the disease development and progression, as well as a lack of robust and valid preclinical human models that can accurately recapitulate the pathophysiology of the human heart. In addition to cardiomyocytes, the heart contains a heterogeneous population of non-myocytes including fibroblasts, vascular cells, autonomic neurons, and immune cells. These cardiac non-myocytes play important roles in cardiac homeostasis and disease, yet the effect of hyperglycaemia and hyperlipidaemia on these cell types is often overlooked in preclinical models of diabetic cardiomyopathy. The advent of human-induced pluripotent stem cells provides a new paradigm in which to model diabetic cardiomyopathy as they can be differentiated into all cell types in the human heart. This review will discuss the roles of cardiac non-myocytes and their dynamic intercellular interactions in the pathogenesis of diabetic cardiomyopathy. We will also discuss the use of sodium-glucose cotransporter 2 inhibitors as a therapy for diabetic cardiomyopathy and their known impacts on non-myocytes. These developments will no doubt facilitate the discovery of novel treatment targets for preventing the onset and progression of diabetic cardiomyopathy.<\/jats:p>","DOI":"10.1093\/cvr\/cvac049","type":"journal-article","created":{"date-parts":[[2022,4,7]],"date-time":"2022-04-07T10:32:05Z","timestamp":1649327525000},"page":"668-690","source":"Crossref","is-referenced-by-count":61,"title":["Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy"],"prefix":"10.1093","volume":"119","author":[{"given":"Ren Jie","family":"Phang","sequence":"first","affiliation":[{"name":"O\u2019Brien Institute Department, St Vincent\u2019s Institute of Medical Research , 9 Princes Street, Fitzroy, VIC 3065 , Australia"},{"name":"Department of Surgery, University of Melbourne , Parkville, VIC 3010 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8610-0058","authenticated-orcid":false,"given":"Rebecca H","family":"Ritchie","sequence":"additional","affiliation":[{"name":"School of Biosciences, University of Melbourne, Parkville, VIC 3010, Australia"},{"name":"Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences , Parkville, VIC 3052 , Australia"},{"name":"Department of Pharmacology, Monash University , Clayton, VIC 3800 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek J","family":"Hausenloy","sequence":"additional","affiliation":[{"name":"National Heart Research Institute Singapore, National Heart Centre Singapore , Singapore , Singapore"},{"name":"Cardiovascular and Metabolic Disorders Programme, Duke-NUS Medical School , Singapore , Singapore"},{"name":"Yong Loo Lin School of Medicine, National University Singapore , Singapore , Singapore"},{"name":"The Hatter Cardiovascular Institute, University College London , London , UK"},{"name":"Cardiovascular Research Center, College of Medical and Health Sciences, Asia University , Taichung City , Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-8657","authenticated-orcid":false,"given":"Jarmon G","family":"Lees","sequence":"additional","affiliation":[{"name":"O\u2019Brien Institute Department, St Vincent\u2019s Institute of Medical Research , 9 Princes Street, Fitzroy, VIC 3065 , Australia"},{"name":"Department of Medicine, University of Melbourne , Parkville, VIC 3010 , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0442-3655","authenticated-orcid":false,"given":"Shiang Y","family":"Lim","sequence":"additional","affiliation":[{"name":"O\u2019Brien Institute Department, St Vincent\u2019s Institute of Medical Research , 9 Princes Street, Fitzroy, VIC 3065 , Australia"},{"name":"Department of Surgery, University of Melbourne , Parkville, VIC 3010 , Australia"},{"name":"Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences , Parkville, VIC 3052 , Australia"},{"name":"National Heart Research Institute Singapore, National Heart Centre Singapore , Singapore , Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,4,7]]},"reference":[{"key":"2023050214505370200_cvac049-B1","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1038\/nrdp.2015.19","article-title":"Type 2 diabetes mellitus","volume":"1","author":"DeFronzo","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2023050214505370200_cvac049-B2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11886-019-1133-9","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"21","author":"Htay","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"2023050214505370200_cvac049-B3","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"2023050214505370200_cvac049-B4","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"2023050214505370200_cvac049-B5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2023050214505370200_cvac049-B6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","article-title":"Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective","volume":"16","author":"Zhu","year":"2016","journal-title":"Curr Diab Rep"},{"key":"2023050214505370200_cvac049-B7","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/MCO.0b013e328348c06d","article-title":"Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?","volume":"14","author":"Esteve","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2023050214505370200_cvac049-B8","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ypmed.2018.11.006","article-title":"Television viewing time, walking time, and risk of type 2 diabetes in Japanese men and women: the Japan collaborative cohort study","volume":"118","author":"Ikehara","year":"2019","journal-title":"Prev Med"},{"key":"2023050214505370200_cvac049-B9","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.2337\/db20-0573","article-title":"The role of TCF7L2 in type 2 diabetes","volume":"70","author":"Del Bosque-Plata","year":"2021","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat Genet"},{"key":"2023050214505370200_cvac049-B11","first-page":"19","article-title":"Insulin and insulin resistance","volume":"26","author":"Wilcox","year":"2005","journal-title":"Clin Biochem Rev"},{"key":"2023050214505370200_cvac049-B12","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1002\/jcp.27603","article-title":"Insulin resistance: review of the underlying molecular mechanisms","volume":"234","author":"Yaribeygi","year":"2019","journal-title":"J Cell Physiol"},{"key":"2023050214505370200_cvac049-B13","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","article-title":"Insulin resistance and heart failure: molecular mechanisms","volume":"8","author":"Aroor","year":"2012","journal-title":"Heart Fail Clin"},{"key":"2023050214505370200_cvac049-B14","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contributions of \u03b2-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"2023050214505370200_cvac049-B15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"2023050214505370200_cvac049-B16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular complications of type 2 diabetes mellitus","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr Vasc Pharmacol"},{"key":"2023050214505370200_cvac049-B17","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023050214505370200_cvac049-B18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4103\/2230-8210.183480","article-title":"Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum?","volume":"20","author":"Chawla","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"2023050214505370200_cvac049-B19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijcard.2019.02.030","article-title":"Microvascular complications in diabetes: a growing concern for cardiologists","volume":"291","author":"Avogaro","year":"2019","journal-title":"Int J Cardiol"},{"key":"2023050214505370200_cvac049-B20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"2023050214505370200_cvac049-B21","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.tips.2015.11.009","article-title":"Potential drug combinations to reduce cardiovascular disease burden in diabetes","volume":"37","author":"Pillarisetti","year":"2016","journal-title":"Trends Pharmacol Sci"},{"key":"2023050214505370200_cvac049-B22","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the american heart association and the american diabetes association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"key":"2023050214505370200_cvac049-B23","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/ehf2.12669","article-title":"Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes","volume":"7","author":"Mordi","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2023050214505370200_cvac049-B24","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1093\/eurheartj\/ehy596","article-title":"Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the Translational Research Committee of the Heart Failure Association-European Society of Cardiology","volume":"39","author":"Maack","year":"2018","journal-title":"Eur Heart J"},{"key":"2023050214505370200_cvac049-B25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCULATIONAHA.118.038602","article-title":"Differential association of genetic risk of coronary artery disease with development of heart failure with reduced versus preserved ejection fraction","volume":"139","author":"Mordi","year":"2019","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10741-019-09838-6","article-title":"The metabolic syndrome in heart failure: insights to specific mechanisms","volume":"25","author":"Gargiulo","year":"2020","journal-title":"Heart Fail Rev"},{"key":"2023050214505370200_cvac049-B27","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1161\/CIRCRESAHA.120.315913","article-title":"Basic mechanisms of diabetic heart disease","volume":"126","author":"Ritchie","year":"2020","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B28","doi-asserted-by":"crossref","first-page":"3264","DOI":"10.3390\/ijms20133264","article-title":"Molecular dysfunction and phenotypic derangement in diabetic cardiomyopathy","volume":"20","author":"Evangelista","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B29","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ejhf.1170","article-title":"Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology","volume":"20","author":"Seferovi\u0107","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"2023050214505370200_cvac049-B30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s00392-006-0351-5","article-title":"Gender differences in the metabolic syndrome and their role for cardiovascular disease","volume":"95","author":"Regitz-Zagrosek","year":"2006","journal-title":"Clin Res Cardiol"},{"key":"2023050214505370200_cvac049-B31","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.numecd.2009.11.012","article-title":"Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience","volume":"21","author":"Donahue","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2023050214505370200_cvac049-B32","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.phrs.2017.01.023","article-title":"Sex-gender-related therapeutic approaches for cardiovascular complications associated with diabetes","volume":"119","author":"Campesi","year":"2017","journal-title":"Pharmacol Res"},{"key":"2023050214505370200_cvac049-B33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.genm.2010.11.003","article-title":"Sex-specific differences in glycemic control and cardiovascular risk factors in older patients with insulin-treated type 2 diabetes mellitus","volume":"7","author":"G\u00f6bl","year":"2010","journal-title":"Gend Med"},{"key":"2023050214505370200_cvac049-B34","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jchf.2019.01.004","article-title":"Sex differences in heart failure with preserved ejection fraction pathophysiology: a detailed invasive hemodynamic and echocardiographic analysis","volume":"7","author":"Beale","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2023050214505370200_cvac049-B35","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12933-021-01248-z","article-title":"Sex-specific differences in left ventricular mass and myocardial energetic efficiency in non-diabetic, pre-diabetic and newly diagnosed type 2 diabetic subjects","volume":"20","author":"Succurro","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B36","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1038\/s41598-018-20703-8","article-title":"Diastolic dysfunction is more apparent in STZ-induced diabetic female mice, despite less pronounced hyperglycemia","volume":"8","author":"Chandramouli","year":"2018","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B37","doi-asserted-by":"crossref","first-page":"661297","DOI":"10.3389\/fphys.2021.661297","article-title":"Sex differences of the diabetic heart","volume":"12","author":"Fourny","year":"2021","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B38","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12933-014-0138-3","article-title":"Biomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitus","volume":"13","author":"G\u00f6bl","year":"2014","journal-title":"Cardiovasc Diabetol"},{"issue":"Suppl. 2","key":"2023050214505370200_cvac049-B39","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0168-8227(01)00339-4","article-title":"Effect of estrogen on endothelial dysfunction in postmenopausal women with diabetes","volume":"54","author":"Lee","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"key":"2023050214505370200_cvac049-B40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.2337\/diacare.25.2.370","article-title":"Early increase of oxidative stress and reduced antioxidant defenses in patients with uncomplicated type 1 diabetes: a case for gender difference","volume":"25","author":"Marra","year":"2002","journal-title":"Diabetes Care"},{"key":"2023050214505370200_cvac049-B41","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1161\/01.CIR.101.17.2040","article-title":"Type II diabetes abrogates sex differences in endothelial function in premenopausal women","volume":"101","author":"Steinberg","year":"2000","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B42","doi-asserted-by":"crossref","first-page":"6961348","DOI":"10.1155\/2020\/6961348","article-title":"Sex differences in progression of diabetic cardiomyopathy in OVE26 type 1 diabetic mice","volume":"2020","author":"Tang","year":"2020","journal-title":"Oxid Med Cell Longev"},{"key":"2023050214505370200_cvac049-B43","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.3390\/ijms20123090","article-title":"Diabetic pregnancy and maternal high-fat diet impair mitochondrial dynamism in the developing fetal rat heart by sex-specific mechanisms","volume":"20","author":"Larsen","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B44","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.3389\/fphys.2018.01514","article-title":"Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control","volume":"9","author":"Borghetti","year":"2018","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B45","doi-asserted-by":"crossref","first-page":"568800","DOI":"10.3389\/fphys.2020.568800","article-title":"Newly discovered adipokines: pathophysiological link between obesity and cardiometabolic disorders","volume":"11","author":"Kim","year":"2020","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B46","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3389\/fcvm.2020.00022","article-title":"Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease","volume":"7","author":"Chait","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"2023050214505370200_cvac049-B47","article-title":"Sex differences of visceral fat area and visceral-to-subcutaneous fat ratio for the risk of incident type 2 diabetes mellitus","author":"Kim","year":"2021","journal-title":"Diabetes Metab J"},{"key":"2023050214505370200_cvac049-B48","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.2337\/db20-1031","article-title":"Perirenal fat thickness is significantly associated with the risk for development of chronic kidney disease in patients with diabetes","volume":"70","author":"Chen","year":"2021","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.5543\/tkda.2021.65635","article-title":"Epicardial adipose tissue volume predicts long term major adverse cardiovascular events in patients with Type 2 diabetes","volume":"49","author":"Uygur","year":"2021","journal-title":"Turk Kardiyol Dern Ars"},{"key":"2023050214505370200_cvac049-B50","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1111\/jgh.15580","article-title":"The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease","volume":"36","author":"Phrueksotsai","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"2023050214505370200_cvac049-B51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/heartjnl-2020-318242","article-title":"Epicardial adipose tissue in obesity-related cardiac dysfunction","volume":"108","author":"Ayton","year":"2022","journal-title":"Heart"},{"key":"2023050214505370200_cvac049-B52","doi-asserted-by":"crossref","first-page":"e0207228","DOI":"10.1371\/journal.pone.0207228","article-title":"CCN5 knockout mice exhibit lipotoxic cardiomyopathy with mild obesity and diabetes","volume":"13","author":"Kim","year":"2018","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B53","doi-asserted-by":"crossref","first-page":"e21504","DOI":"10.1096\/fj.202002562R","article-title":"Cell death-inducing DFFA-like effector C\/CIDEC gene silencing alleviates diabetic cardiomyopathy via upregulating AMPKa phosphorylation","volume":"35","author":"Zhou","year":"2021","journal-title":"FASEB J"},{"key":"2023050214505370200_cvac049-B54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2017.08.023","article-title":"Rutin alleviates diabetic cardiomyopathy and improves cardiac function in diabetic ApoEknockout mice","volume":"814","author":"Huang","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"2023050214505370200_cvac049-B55","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2020.01.018","article-title":"Lipid accumulation in hearts transplanted from nondiabetic donors to diabetic recipients","volume":"75","author":"Marfella","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2023050214505370200_cvac049-B56","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1161\/CIRCRESAHA.109.209197","article-title":"Epicardial-myocardial signaling directing coronary vasculogenesis","volume":"106","author":"Olivey","year":"2010","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B57","doi-asserted-by":"crossref","first-page":"300060520926737","DOI":"10.1177\/0300060520926737","article-title":"Pericardial adipose tissue is an independent risk factor of coronary artery disease and is associated with risk factors of coronary artery disease","volume":"48","author":"Si","year":"2020","journal-title":"J Int Med Res"},{"key":"2023050214505370200_cvac049-B58","doi-asserted-by":"crossref","first-page":"e018080","DOI":"10.1161\/JAHA.120.018080","article-title":"Association of epicardial fat volume with increased risk of obstructive coronary artery disease in chinese patients with suspected coronary artery disease","volume":"10","author":"Yu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2023050214505370200_cvac049-B59","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12933-019-0917-y","article-title":"Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes","volume":"18","author":"Christensen","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B60","doi-asserted-by":"crossref","first-page":"107552","DOI":"10.1016\/j.jdiacomp.2020.107552","article-title":"Epicardial adipose tissue is tightly associated with exercise intolerance in patients with type 2 diabetes mellitus with asymptomatic left ventricular structural and functional abnormalities","volume":"34","author":"Sugita","year":"2020","journal-title":"J Diabetes Complicat"},{"key":"2023050214505370200_cvac049-B61","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1111\/dom.13758","article-title":"Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes","volume":"21","author":"Christensen","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2023050214505370200_cvac049-B62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12944-018-0856-8","article-title":"Localization of fat depots and cardiovascular risk","volume":"17","author":"Gruzdeva","year":"2018","journal-title":"Lipids Health Dis"},{"key":"2023050214505370200_cvac049-B63","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1177\/0003319720984607","article-title":"Association of epicardial fat volume with the extent of coronary atherosclerosis and cardiovascular adverse events in asymptomatic patients with diabetes","volume":"72","author":"Venuraju","year":"2021","journal-title":"Angiology"},{"key":"2023050214505370200_cvac049-B64","doi-asserted-by":"crossref","first-page":"e21878","DOI":"10.1096\/fj.202100684RR","article-title":"Potential role of epicardial adipose tissue in coronary artery endothelial cell dysfunction in type 2 diabetes","volume":"35","author":"Ballasy","year":"2021","journal-title":"FASEB J"},{"key":"2023050214505370200_cvac049-B65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-021-01374-8","article-title":"The association of hepatic steatosis and fibrosis with heart failure and mortality","volume":"20","author":"Park","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B66","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12872-020-01444-x","article-title":"Higher fatty liver index is associated with increased risk of new onset heart failure in healthy adults: a nationwide population-based study in Korea","volume":"20","author":"Roh","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2023050214505370200_cvac049-B67","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/dom.14597","article-title":"Young adults with nonalcoholic fatty liver disease, defined using the fatty liver index, can be at increased risk of myocardial infarction or stroke","volume":"24","author":"Chung","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"2023050214505370200_cvac049-B68","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/cells9030567","article-title":"Relationship between heart disease and liver disease: a two-way street","volume":"9","author":"El Hadi","year":"2020","journal-title":"Cells"},{"key":"2023050214505370200_cvac049-B69","doi-asserted-by":"crossref","first-page":"3327","DOI":"10.1210\/jc.2018-02414","article-title":"Plasma fibroblast growth factor 21 is associated with severity of nonalcoholic steatohepatitis in patients with obesity and type 2 diabetes","volume":"104","author":"Barb","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"2023050214505370200_cvac049-B70","doi-asserted-by":"crossref","first-page":"5163245","DOI":"10.1155\/2019\/5163245","article-title":"Serum fibroblast growth factor 21 levels are positively associated with metabolic syndrome in patients with type 2 diabetes","volume":"2019","author":"Gao","year":"2019","journal-title":"Int J Endocrinol"},{"key":"2023050214505370200_cvac049-B71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-021-01439-8","article-title":"Fetuin-A and risk of diabetes-related vascular complications: a prospective study","volume":"21","author":"Birukov","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B72","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12933-020-01127-z","article-title":"Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial","volume":"19","author":"Shimizu","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B73","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1016\/j.numecd.2021.08.037","article-title":"Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic\/parasympathetic balance in subjects with and without type 2 diabetes\u2014the Cooperative Health Research in South Tyrol (CHRIS)-NAFLD sub-study","volume":"31","author":"Targher","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2023050214505370200_cvac049-B74","doi-asserted-by":"crossref","first-page":"20570","DOI":"10.1038\/s41598-021-99891-9","article-title":"Ventricular arrhythmias in mouse models of diabetic kidney disease","volume":"11","author":"Laurita","year":"2021","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B75","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40885-021-00185-z","article-title":"A pilot study investigating the relationship between heart rate variability and blood pressure in young adults at risk for cardiovascular disease","volume":"28","author":"Bolin","year":"2022","journal-title":"Clin Hypertens"},{"key":"2023050214505370200_cvac049-B76","doi-asserted-by":"crossref","first-page":"H1328","DOI":"10.1152\/ajpheart.00249.2019","article-title":"Increased arrhythmia susceptibility in type 2 diabetic mice related to dysregulation of ventricular sympathetic innervation","volume":"317","author":"Jungen","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023050214505370200_cvac049-B77","doi-asserted-by":"crossref","first-page":"476279","DOI":"10.1155\/2010\/476279","article-title":"Pathogenesis of insulin resistance in skeletal muscle","volume":"2010","author":"Abdul-Ghani","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"2023050214505370200_cvac049-B78","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41467-021-27634-5","article-title":"Skeletal muscle derived Musclin protects the heart during pathological overload","volume":"13","author":"Szaroszyk","year":"2022","journal-title":"Nat Commun"},{"key":"2023050214505370200_cvac049-B79","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00125-014-3224-x","article-title":"Myokines in insulin resistance and type 2 diabetes","volume":"57","author":"Eckardt","year":"2014","journal-title":"Diabetologia"},{"key":"2023050214505370200_cvac049-B80","doi-asserted-by":"crossref","first-page":"709039","DOI":"10.3389\/fphys.2021.709039","article-title":"Treadmill training effect on the myokines content in skeletal muscles of mice with a metabolic disorder model","volume":"12","author":"Zakharova","year":"2021","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B81","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.3390\/cells10123480","article-title":"Exercise inhibits NLRP3 inflammasome activation in obese mice via the anti-inflammatory effect of meteorin-like","volume":"10","author":"Javaid","year":"2021","journal-title":"Cells"},{"key":"2023050214505370200_cvac049-B82","doi-asserted-by":"crossref","first-page":"9327","DOI":"10.3390\/ijms22179327","article-title":"Exploring the role of skeletal muscle in insulin resistance: lessons from cultured cells to animal models","volume":"22","author":"Feraco","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B83","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41419-021-03922-2","article-title":"Osteocrin, a novel myokine, prevents diabetic cardiomyopathy via restoring proteasomal activity","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"key":"2023050214505370200_cvac049-B84","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.3390\/cells10082103","article-title":"Role of irisin in myocardial infarction, heart failure, and cardiac hypertrophy","volume":"10","author":"Ho","year":"2021","journal-title":"Cells"},{"key":"2023050214505370200_cvac049-B85","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2014.04.036","article-title":"Circulating irisin levels are positively associated with endothelium-dependent vasodilation in newly diagnosed type 2 diabetic patients without clinical angiopathy","volume":"235","author":"Xiang","year":"2014","journal-title":"Atherosclerosis"},{"key":"2023050214505370200_cvac049-B86","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.yjmcc.2021.06.013","article-title":"FNDC5\/Irisin attenuates diabetic cardiomyopathy in a type 2 diabetes mouse model by activation of integrin \u03b1V\/\u03b25-AKT signaling and reduction of oxidative\/nitrosative stress","volume":"160","author":"Lin","year":"2021","journal-title":"J Mol Cell Cardiol"},{"key":"2023050214505370200_cvac049-B87","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1002\/cbin.11441","article-title":"Irisin ameliorates high glucose-induced cardiomyocytes injury via AMPK\/mTOR signal pathway","volume":"44","author":"Deng","year":"2020","journal-title":"Cell Biol Int"},{"key":"2023050214505370200_cvac049-B88","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2174\/0929867324666170705111356","article-title":"Clinical approach to diabetic cardiomyopathy: a review of human studies","volume":"25","author":"Tarquini","year":"2018","journal-title":"Curr Med Chem"},{"key":"2023050214505370200_cvac049-B89","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1136\/jcp.46.1.32","article-title":"Collagen remodelling in myocardia of patients with diabetes","volume":"46","author":"Shimizu","year":"1993","journal-title":"J Clin Pathol"},{"key":"2023050214505370200_cvac049-B90","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacc.2017.11.019","article-title":"Implications of underlying mechanisms for the recognition and management of diabetic cardiomyopathy","volume":"71","author":"Marwick","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2023050214505370200_cvac049-B91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11010-006-9401-6","article-title":"High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1\/2","volume":"301","author":"Tang","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"2023050214505370200_cvac049-B92","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/cphy.c140063","article-title":"Cardiac physiology of aging: extracellular considerations","volume":"5","author":"Horn","year":"2015","journal-title":"Compr Physiol"},{"key":"2023050214505370200_cvac049-B93","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00004872-200301000-00002","article-title":"Cross-linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes","volume":"21","author":"Aronson","year":"2003","journal-title":"J Hypertens"},{"key":"2023050214505370200_cvac049-B94","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/CIRCRESAHA.109.209809","article-title":"Cardiac fibroblast: the renaissance cell","volume":"105","author":"Souders","year":"2009","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B95","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.yjmcc.2015.12.011","article-title":"Diabetes-associated cardiac fibrosis: cellular effectors, molecular mechanisms and therapeutic opportunities","volume":"90","author":"Russo","year":"2016","journal-title":"J Mol Cell Cardiol"},{"key":"2023050214505370200_cvac049-B96","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/eht193","article-title":"Myocardial extracellular volume fraction quantified by cardiovascular magnetic resonance is increased in diabetes and associated with mortality and incident heart failure admission","volume":"35","author":"Wong","year":"2014","journal-title":"Eur Heart J"},{"key":"2023050214505370200_cvac049-B97","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ajhb.21137","article-title":"Evaluation of specific metabolic rates of major organs and tissues: comparison between men and women","volume":"23","author":"Wang","year":"2011","journal-title":"Am J Hum Biol"},{"key":"2023050214505370200_cvac049-B98","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/cvr\/cvn093","article-title":"Insulin signalling in the heart","volume":"79","author":"Bertrand","year":"2008","journal-title":"Cardiovasc Res"},{"key":"2023050214505370200_cvac049-B99","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.3390\/ijms20112833","article-title":"Contribution of impaired insulin signaling to the pathogenesis of diabetic cardiomyopathy","volume":"20","author":"Zamora","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B100","doi-asserted-by":"crossref","first-page":"695792","DOI":"10.3389\/fmed.2021.695792","article-title":"The diabetic cardiomyopathy: the contributing pathophysiological mechanisms","volume":"8","author":"Salvatore","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2023050214505370200_cvac049-B101","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-17-0724","article-title":"Mechanisms in endocrinology: diabetic cardiomyopathy: pathophysiology and potential metabolic interventions state of the art review","volume":"178","author":"Levelt","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2023050214505370200_cvac049-B102","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.metabol.2017.08.005","article-title":"The diabetic heart utilizes ketone bodies as an energy source","volume":"77","author":"Mizuno","year":"2017","journal-title":"Metabolism"},{"key":"2023050214505370200_cvac049-B103","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/dom.13536","article-title":"Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: a hyperpolarized 13C magnetic resonance spectroscopy study","volume":"21","author":"Abdurrachim","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"2023050214505370200_cvac049-B104","doi-asserted-by":"crossref","first-page":"e013039","DOI":"10.1161\/JAHA.119.013039","article-title":"Increased glucose availability attenuates myocardial ketone body utilization","volume":"9","author":"Brahma","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"2023050214505370200_cvac049-B105","first-page":"859","article-title":"Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state","volume":"168","author":"Chiasson","year":"2003","journal-title":"CMAJ"},{"key":"2023050214505370200_cvac049-B106","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4093\/dmj.2019.0185","article-title":"Mitochondrial mechanisms in diabetic cardiomyopathy","volume":"44","author":"Gollmer","year":"2020","journal-title":"Diabetes Metab J"},{"key":"2023050214505370200_cvac049-B107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10741-013-9388-5","article-title":"Structural changes in the myocardium during diabetes-induced cardiomyopathy","volume":"19","author":"Adeghate","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2023050214505370200_cvac049-B108","doi-asserted-by":"crossref","first-page":"14783","DOI":"10.1016\/S0021-9258(18)33348-9","article-title":"Studies on the interaction of palmitoyl coenzyme a with the adenine nucleotide translocase","volume":"257","author":"Woldegiorgis","year":"1982","journal-title":"J Biol Chem"},{"key":"2023050214505370200_cvac049-B109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0952-3278(95)90016-0","article-title":"Fatty acyl CoA esters as regulators of cell metabolism","volume":"52","author":"Shrago","year":"1995","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2023050214505370200_cvac049-B110","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","article-title":"Myocardial fatty acid metabolism in health and disease","volume":"90","author":"Lopaschuk","year":"2010","journal-title":"Physiol Rev"},{"key":"2023050214505370200_cvac049-B111","doi-asserted-by":"crossref","first-page":"26","DOI":"10.12997\/jla.2019.8.1.26","article-title":"Established and emerging mechanisms of diabetic cardiomyopathy","volume":"8","author":"Gollmer","year":"2019","journal-title":"J Lipid Atheroscler"},{"key":"2023050214505370200_cvac049-B112","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11897-013-0133-0","article-title":"Cardiac lipotoxicity: molecular pathways and therapeutic implications","volume":"10","author":"Drosatos","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"2023050214505370200_cvac049-B113","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pharmthera.2016.11.013","article-title":"Cardiac oxidative stress in diabetes: mechanisms and therapeutic potential","volume":"172","author":"Faria","year":"2017","journal-title":"Pharmacol Ther"},{"key":"2023050214505370200_cvac049-B114","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pharmthera.2014.01.003","article-title":"Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways","volume":"142","author":"Huynh","year":"2014","journal-title":"Pharmacol Ther"},{"key":"2023050214505370200_cvac049-B115","doi-asserted-by":"crossref","first-page":"114209","DOI":"10.1016\/j.bcp.2020.114209","article-title":"A novel oral glucagon-like peptide 1 receptor agonist protects against diabetic cardiomyopathy via alleviating cardiac lipotoxicity induced mitochondria dysfunction","volume":"182","author":"Qian","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"2023050214505370200_cvac049-B116","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.yjmcc.2014.09.022","article-title":"Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1\/AMPK pathway","volume":"77","author":"Zhang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2023050214505370200_cvac049-B117","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocr Rev"},{"key":"2023050214505370200_cvac049-B118","doi-asserted-by":"crossref","first-page":"647","DOI":"10.14336\/AD.2017.0924","article-title":"Pkc\u03b4 activation is involved in ROS-mediated mitochondrial dysfunction and apoptosis in cardiomyocytes exposed to advanced glycation end products (ages)","volume":"9","author":"Yang","year":"2018","journal-title":"Aging Dis"},{"key":"2023050214505370200_cvac049-B119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41401-018-0042-6","article-title":"Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy","volume":"40","author":"Knapp","year":"2019","journal-title":"Acta Pharmacol Sin"},{"key":"2023050214505370200_cvac049-B120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.freeradbiomed.2015.11.013","article-title":"Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy","volume":"90","author":"Ni","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"2023050214505370200_cvac049-B121","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fphys.2018.00114","article-title":"Oxidative stress and NLRP3-inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications","volume":"9","author":"Sharma","year":"2018","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B122","doi-asserted-by":"crossref","first-page":"e104771","DOI":"10.1371\/journal.pone.0104771","article-title":"NLRP3 gene silencing ameliorates diabetic cardiomyopathy in a type 2 diabetes rat model","volume":"9","author":"Luo","year":"2014","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B123","doi-asserted-by":"crossref","first-page":"99740","DOI":"10.18632\/oncotarget.20763","article-title":"NLRP3-inflammasome inhibition prevents high fat and high sugar diets-induced heart damage through autophagy induction","volume":"8","author":"Pavillard","year":"2017","journal-title":"Oncotarget"},{"key":"2023050214505370200_cvac049-B124","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1573399810666140508121012","article-title":"Leptin- and leptin receptor-deficient rodent models: relevance for human type 2 diabetes","volume":"10","author":"Wang","year":"2014","journal-title":"Curr Diabetes Rev"},{"key":"2023050214505370200_cvac049-B125","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.20082596","article-title":"Cardiac 12\/15 lipoxygenase-induced inflammation is involved in heart failure","volume":"206","author":"Kayama","year":"2009","journal-title":"J Exp Med"},{"key":"2023050214505370200_cvac049-B126","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1016\/j.ijcard.2013.07.150","article-title":"An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy","volume":"168","author":"Palomer","year":"2013","journal-title":"Int J Cardiol"},{"key":"2023050214505370200_cvac049-B127","doi-asserted-by":"crossref","first-page":"e2690","DOI":"10.1038\/cddis.2017.106","article-title":"Salusin-\u03b2 contributes to oxidative stress and inflammation in diabetic cardiomyopathy","volume":"8","author":"Zhao","year":"2017","journal-title":"Cell Death Dis"},{"key":"2023050214505370200_cvac049-B128","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1002\/ehf2.13431","article-title":"Ryanodine receptor and immune-related molecules in diabetic cardiomyopathy","volume":"8","author":"Tian","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2023050214505370200_cvac049-B129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00125-017-4390-4","article-title":"Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease","volume":"61","author":"Jia","year":"2018","journal-title":"Diabetologia"},{"key":"2023050214505370200_cvac049-B130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3389\/fcvm.2018.00143","article-title":"Heterocellularity and cellular cross-talk in the cardiovascular system","volume":"5","author":"Perbellini","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2023050214505370200_cvac049-B131","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00592-019-01393-8","article-title":"Impact of blood glucose control on sympathetic and vagus nerve functional status in patients with type 2 diabetes mellitus","volume":"57","author":"Yu","year":"2020","journal-title":"Acta Diabetol"},{"key":"2023050214505370200_cvac049-B132","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10741-013-9378-7","article-title":"Role of microangiopathy in diabetic cardiomyopathy","volume":"19","author":"Adameova","year":"2014","journal-title":"Heart Fail Rev"},{"key":"2023050214505370200_cvac049-B133","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/CIRCRESAHA.115.307778","article-title":"Revisiting cardiac cellular composition","volume":"118","author":"Pinto","year":"2016","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B134","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3390\/ijms21030970","article-title":"The diabetic cardiac fibroblast: mechanisms underlying phenotype and function","volume":"21","author":"Levick","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B135","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12933-021-01303-9","article-title":"Diastolic dysfunction in a pre-clinical model of diabetes is associated with changes in the cardiac non-myocyte cellular composition","volume":"20","author":"Cohen","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B136","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The extracellular matrix in ischemic and nonischemic heart failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B137","doi-asserted-by":"crossref","first-page":"e72080","DOI":"10.1371\/journal.pone.0072080","article-title":"Cardiac fibroblast-dependent extracellular matrix accumulation is associated with diastolic stiffness in type 2 diabetes","volume":"8","author":"Hutchinson","year":"2013","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B138","doi-asserted-by":"crossref","first-page":"H227","DOI":"10.1152\/ajpheart.00340.2004","article-title":"Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E","volume":"288","author":"Asbun","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023050214505370200_cvac049-B139","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.bbrc.2005.11.060","article-title":"Thrombospondin 1 mediates angiotensin II induction of TGF-\u03b2 activation by cardiac and renal cells under both high and low glucose conditions","volume":"339","author":"Zhou","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2023050214505370200_cvac049-B140","doi-asserted-by":"crossref","first-page":"H1675","DOI":"10.1152\/ajpheart.91493.2007","article-title":"Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production","volume":"294","author":"Singh","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023050214505370200_cvac049-B141","doi-asserted-by":"crossref","first-page":"C794","DOI":"10.1152\/ajpcell.00251.2013","article-title":"Role for high-glucose-induced protein O-GlcNAcylation in stimulating cardiac fibroblast collagen synthesis","volume":"306","author":"Aguilar","year":"2014","journal-title":"Am J Physiol Cell Physiol"},{"key":"2023050214505370200_cvac049-B142","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11626-007-9052-2","article-title":"Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix","volume":"43","author":"Zhang","year":"2007","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"2023050214505370200_cvac049-B143","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1139\/cjpp-2013-0490","article-title":"Hyperglycemia enhances function and differentiation of adult rat cardiac fibroblasts","volume":"92","author":"Shamhart","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"2023050214505370200_cvac049-B144","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1291\/hypres.29.711","article-title":"Pressure overload-induced transient oxidative stress mediates perivascular inflammation and cardiac fibrosis through angiotensin II","volume":"29","author":"Kai","year":"2006","journal-title":"Hypertens Res"},{"key":"2023050214505370200_cvac049-B145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2023050214505370200_cvac049-B146","doi-asserted-by":"crossref","first-page":"H2931","DOI":"10.1152\/ajpheart.01220.2004","article-title":"K+ currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts","volume":"288","author":"Chilton","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023050214505370200_cvac049-B147","doi-asserted-by":"crossref","first-page":"H1010","DOI":"10.1152\/ajpheart.01195.2007","article-title":"Neonatal rat cardiac fibroblasts express three types of voltage-gated K+ channels: regulation of a transient outward current by protein kinase C","volume":"294","author":"Walsh","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023050214505370200_cvac049-B148","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/CIRCULATIONAHA.117.028976","article-title":"Increased cardiac arrhythmogenesis associated with gap junction remodeling with upregulation of RNA-binding protein FXR1","volume":"137","author":"Chu","year":"2018","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B149","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrcardio.2012.145","article-title":"Altered sarcoplasmic reticulum calcium cycling\u2013targets for heart failure therapy","volume":"9","author":"Kho","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"2023050214505370200_cvac049-B150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1134\/S0026893314040025","article-title":"High glucose promotes gap junctional communication in cultured neonatal cardiac fibroblasts via AMPK activation","volume":"48","author":"Chen","year":"2014","journal-title":"Mol Biol (Mosk)"},{"key":"2023050214505370200_cvac049-B151","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1582-4934.2009.00731.x","article-title":"The anti-angiogenic factor PEDF is present in the human heart and is regulated by anoxia in cardiac myocytes and fibroblasts","volume":"14","author":"Rychli","year":"2010","journal-title":"J Cell Mol Med"},{"key":"2023050214505370200_cvac049-B152","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature13839","article-title":"Mesenchymal-endothelial transition contributes to cardiac neovascularization","volume":"514","author":"Ubil","year":"2014","journal-title":"Nature"},{"key":"2023050214505370200_cvac049-B153","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jacbts.2019.02.006","article-title":"Fibroblasts in the infarcted, remodeling, and failing heart","volume":"4","author":"Humeres","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2023050214505370200_cvac049-B154","doi-asserted-by":"crossref","first-page":"4396368","DOI":"10.1155\/2016\/4396368","article-title":"The CXCL10\/CXCR3 axis and cardiac inflammation: implications for immunotherapy to treat infectious and noninfectious diseases of the heart","volume":"2016","author":"Altara","year":"2016","journal-title":"J Immunol Res"},{"key":"2023050214505370200_cvac049-B155","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1016\/j.bbadis.2018.08.026","article-title":"Exosomal Mst1 transfer from cardiac microvascular endothelial cells to cardiomyocytes deteriorates diabetic cardiomyopathy","volume":"1864","author":"Hu","year":"2018","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2023050214505370200_cvac049-B156","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/cvr\/cvw159","article-title":"Endothelial cell-cardiomyocyte crosstalk in diabetic cardiomyopathy","volume":"111","author":"Wan","year":"2016","journal-title":"Cardiovasc Res"},{"key":"2023050214505370200_cvac049-B157","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.15252\/emmm.201404156","article-title":"Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease","volume":"6","author":"Goveia","year":"2014","journal-title":"EMBO Mol Med"},{"key":"2023050214505370200_cvac049-B158","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijdm.2010.09.002","article-title":"Endothelial cell dysfunction in hyperglycemia: phenotypic change, intracellular signaling modification, ultrastructural alteration, and potential clinical outcomes","volume":"2","author":"Popov","year":"2010","journal-title":"Int J Diabetes Mellit"},{"key":"2023050214505370200_cvac049-B159","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00259-012-2117-9","article-title":"Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease","volume":"39","author":"Marciano","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2023050214505370200_cvac049-B160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jacbts.2017.05.004","article-title":"Nitric oxide signaling in heart failure with preserved ejection fraction","volume":"2","author":"Cruz","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"2023050214505370200_cvac049-B161","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.bbadis.2013.08.006","article-title":"Endothelial dysfunction\u2014a major mediator of diabetic vascular disease","volume":"1832","author":"Sena","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"2023050214505370200_cvac049-B162","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ejhf.711","article-title":"Prevention of the development of heart failure with preserved ejection fraction by the phosphodiesterase-5A inhibitor vardenafil in rats with type 2 diabetes","volume":"19","author":"M\u00e1ty\u00e1s","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"2023050214505370200_cvac049-B163","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.116.306923","article-title":"Molecular and cellular mechanisms of cardiovascular disorders in diabetes","volume":"118","author":"Shah","year":"2016","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B164","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1161\/CIRCULATIONAHA.110.938217","article-title":"Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition","volume":"121","author":"Widyantoro","year":"2010","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B165","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/cvr\/cvx011","article-title":"An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy","volume":"113","author":"Frati","year":"2017","journal-title":"Cardiovasc Res"},{"key":"2023050214505370200_cvac049-B166","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.bbrc.2017.07.101","article-title":"MiR-18a-5p inhibits endothelial-mesenchymal transition and cardiac fibrosis through the Notch2 pathway","volume":"491","author":"Geng","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2023050214505370200_cvac049-B167","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/db15-1033","article-title":"miR-200b mediates endothelial-to-mesenchymal transition in diabetic cardiomyopathy","volume":"65","author":"Feng","year":"2016","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B168","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.2147\/DMSO.S287287","article-title":"Sirt6-mediated endothelial-to-mesenchymal transition contributes toward diabetic cardiomyopathy via the Notch1 signaling pathway","volume":"13","author":"Zhang","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2023050214505370200_cvac049-B169","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.7150\/thno.48530","article-title":"A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis","volume":"11","author":"Du","year":"2021","journal-title":"Theranostics"},{"key":"2023050214505370200_cvac049-B170","doi-asserted-by":"crossref","first-page":"E257","DOI":"10.1152\/ajpendo.00348.2014","article-title":"Diabetes and hyperlipidemia induce dysfunction of VSMCs: contribution of the metabolic inflammation\/miRNA pathway","volume":"308","author":"Li","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2023050214505370200_cvac049-B171","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3892\/mmr.2013.1350","article-title":"The effect of telomerase activity on vascular smooth muscle cell proliferation in type 2 diabetes in vivo and in vitro","volume":"7","author":"Sun","year":"2013","journal-title":"Mol Med Rep"},{"key":"2023050214505370200_cvac049-B172","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fphar.2020.00635","article-title":"Metformin and vascular diseases: a focused review on smooth muscle cell function","volume":"11","author":"Deng","year":"2020","journal-title":"Front Pharmacol"},{"key":"2023050214505370200_cvac049-B173","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/ATVBAHA.115.306770","article-title":"Regulation of vascular smooth muscle cell dysfunction under diabetic conditions by miR-504","volume":"36","author":"Reddy","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023050214505370200_cvac049-B174","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.atherosclerosis.2007.12.060","article-title":"Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells","volume":"201","author":"Cifarelli","year":"2008","journal-title":"Atherosclerosis"},{"key":"2023050214505370200_cvac049-B175","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2020.04.018","article-title":"Patient hiPSCs identify vascular smooth muscle arylacetamide deacetylase as protective against atherosclerosis","volume":"27","author":"Toyohara","year":"2020","journal-title":"Cell Stem Cell"},{"key":"2023050214505370200_cvac049-B176","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/cells10030548","article-title":"Emerging role of pericytes and their secretome in the heart","volume":"10","author":"Su","year":"2021","journal-title":"Cells"},{"key":"2023050214505370200_cvac049-B177","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jdiacomp.2016.08.005","article-title":"Pericytes in diabetes-associated vascular disease","volume":"30","author":"Warmke","year":"2016","journal-title":"J Diabetes Complicat"},{"key":"2023050214505370200_cvac049-B178","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/nm834","article-title":"Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy","volume":"9","author":"Hammes","year":"2003","journal-title":"Nat Med"},{"key":"2023050214505370200_cvac049-B179","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2016.10.058","article-title":"Diabetes mellitus-induced microvascular destabilization in the myocardium","volume":"69","author":"Hinkel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2023050214505370200_cvac049-B180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/db10-0454","article-title":"Diabetic retinopathy: targeting vasoregression","volume":"60","author":"Hammes","year":"2011","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B181","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/db19-0471","article-title":"Pericyte bridges in homeostasis and hyperglycemia","volume":"69","author":"Corliss","year":"2020","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B182","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1038\/s41598-019-41253-7","article-title":"Amelioration of diabetic nephropathy by SGLT2 inhibitors independent of its glucose-lowering effect: a possible role of SGLT2 in mesangial cells","volume":"9","author":"Maki","year":"2019","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B183","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1161\/hh1101.091265","article-title":"Sodium-coupled glucose transporter as a functional glucose sensor of retinal microvascular circulation","volume":"88","author":"Wakisaka","year":"2001","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B184","doi-asserted-by":"crossref","first-page":"5668","DOI":"10.3390\/ijms20225668","article-title":"Lessons from the trials for the desirable effects of sodium glucose co-transporter 2 inhibitors on diabetic cardiovascular events and renal dysfunction","volume":"20","author":"Wakisaka","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B185","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.jacc.2018.12.064","article-title":"Autonomic nervous system dysfunction: JACC focus seminar","volume":"73","author":"Goldberger","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023050214505370200_cvac049-B186","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3389\/fphar.2018.00904","article-title":"New insights in cardiac \u03b2-adrenergic signaling during heart failure and aging","volume":"9","author":"de Lucia","year":"2018","journal-title":"Front Pharmacol"},{"key":"2023050214505370200_cvac049-B187","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.3389\/fphys.2018.01669","article-title":"Diabetes and arrhythmias: pathophysiology, mechanisms and therapeutic outcomes","volume":"9","author":"Grisanti","year":"2018","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B188","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1186\/s13104-018-3692-z","article-title":"Poor glycemic control impacts heart rate variability in patients with type 2 diabetes mellitus: a cross sectional study","volume":"11","author":"Nganou-Gnindjio","year":"2018","journal-title":"BMC Res Notes"},{"key":"2023050214505370200_cvac049-B189","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1161\/CIRCULATIONAHA.106.634949","article-title":"Diabetic cardiovascular autonomic neuropathy","volume":"115","author":"Vinik","year":"2007","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B190","doi-asserted-by":"crossref","first-page":"251","DOI":"10.14797\/mdcj-14-4-251","article-title":"Cardiac autonomic neuropathy in diabetes mellitus","volume":"14","author":"Agashe","year":"2018","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"2023050214505370200_cvac049-B191","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1007\/s00125-020-05310-5","article-title":"Association of cardiac autonomic dysfunction with higher levels of plasma lipid metabolites in recent-onset type 2 diabetes","volume":"64","author":"Ziegler","year":"2021","journal-title":"Diabetologia"},{"key":"2023050214505370200_cvac049-B192","doi-asserted-by":"crossref","first-page":"e0195166","DOI":"10.1371\/journal.pone.0195166","article-title":"Heart rate variability in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"13","author":"Benichou","year":"2018","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B193","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.jcmg.2010.09.014","article-title":"Association of cardiac autonomic neuropathy with subclinical myocardial dysfunction in type 2 diabetes","volume":"3","author":"Sacre","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"2023050214505370200_cvac049-B194","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/08990220.2020.1756245","article-title":"The association between cardiac autonomic neuropathy and heart function in type 2 diabetic patients","volume":"37","author":"Lee","year":"2020","journal-title":"Somatosens Mot Res"},{"key":"2023050214505370200_cvac049-B195","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1113\/JP273314","article-title":"High-fat diet induces protein kinase A and G-protein receptor kinase phosphorylation of \u03b22-adrenergic receptor and impairs cardiac adrenergic reserve in animal hearts","volume":"595","author":"Fu","year":"2017","journal-title":"J Physiol"},{"key":"2023050214505370200_cvac049-B196","doi-asserted-by":"crossref","first-page":"e012273","DOI":"10.1161\/JAHA.119.012273","article-title":"Phosphodiesterase 5 associates with \u03b22 adrenergic receptor to modulate cardiac function in type 2 diabetic hearts","volume":"8","author":"West","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"2023050214505370200_cvac049-B197","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.3389\/fphys.2018.01281","article-title":"The role of neuropeptide Y in cardiovascular health and disease","volume":"9","author":"Tan","year":"2018","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B198","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1017\/S1462399411001979","article-title":"Diabetic neuropathy and heart failure: role of neuropeptides","volume":"13","author":"Ejaz","year":"2011","journal-title":"Expert Rev Mol Med"},{"key":"2023050214505370200_cvac049-B199","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2337\/diab.38.2.231","article-title":"Altered acetylcholine and norepinephrine concentrations in diabetic rat hearts. Role of parasympathetic nervous system in diabetic cardiomyopathy","volume":"38","author":"Akiyama","year":"1989","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B200","first-page":"E734","article-title":"Norepinephrine storage, distribution, and release in diabetic cardiomyopathy","volume":"252","author":"Ganguly","year":"1987","journal-title":"Am J Physiol"},{"key":"2023050214505370200_cvac049-B201","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","article-title":"Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study","volume":"52","author":"Duncan","year":"2003","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B202","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B203","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1161\/CIRCRESAHA.116.302317","article-title":"Innate immunity and the failing heart: the cytokine hypothesis revisited","volume":"116","author":"Mann","year":"2015","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B204","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","article-title":"Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling","volume":"131","author":"Frieler","year":"2015","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B205","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.3390\/ijms20133299","article-title":"Cardiomyopathy associated with diabetes: the central role of the cardiomyocyte","volume":"20","author":"Filardi","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B206","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.molmed.2019.01.002","article-title":"Macrophages in heart failure with reduced versus preserved ejection fraction","volume":"25","author":"DeBerge","year":"2019","journal-title":"Trends Mol Med"},{"key":"2023050214505370200_cvac049-B207","doi-asserted-by":"crossref","first-page":"e16239","DOI":"10.1371\/journal.pone.0016239","article-title":"Hyperglycemic myocardial damage is mediated by proinflammatory cytokine: macrophage migration inhibitory factor","volume":"6","author":"Yu","year":"2011","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B208","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.2337\/dc12-1224","article-title":"Human leukocyte\/endothelial cell interactions and mitochondrial dysfunction in type 2 diabetic patients and their association with silent myocardial ischemia","volume":"36","author":"Hernandez-Mijares","year":"2013","journal-title":"Diabetes Care"},{"key":"2023050214505370200_cvac049-B209","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3389\/fphys.2018.01547","article-title":"The role of leukocytes in diabetic cardiomyopathy","volume":"9","author":"Bajpai","year":"2018","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B210","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.numecd.2019.05.063","article-title":"The number and phenotype of myocardial and adipose tissue CD68+ cells is associated with cardiovascular and metabolic disease in heart surgery patients","volume":"29","author":"Pierzynov\u00e1","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2023050214505370200_cvac049-B211","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF03347084","article-title":"PPAR\u03b1 agonist prevented the apoptosis induced by glucose and fatty acid in neonatal cardiomyocytes","volume":"34","author":"Nan","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"2023050214505370200_cvac049-B212","doi-asserted-by":"crossref","first-page":"e90663","DOI":"10.1371\/journal.pone.0090663","article-title":"Relation of leukocytes and its subsets counts with the severity of stable coronary artery disease in patients with diabetic mellitus","volume":"9","author":"Hong","year":"2014","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B213","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1600-065X.2010.00963.x","article-title":"Lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors","volume":"238","author":"Kondo","year":"2010","journal-title":"Immunol Rev"},{"key":"2023050214505370200_cvac049-B214","first-page":"187","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur Heart J"},{"key":"2023050214505370200_cvac049-B215","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/nm.3887","article-title":"Diabetes primes neutrophils to undergo NETosis, which impairs wound healing","volume":"21","author":"Wong","year":"2015","journal-title":"Nat Med"},{"key":"2023050214505370200_cvac049-B216","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2015.11.008","article-title":"A perspective on NETosis in diabetes and cardiometabolic disorders","volume":"26","author":"Fadini","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2023050214505370200_cvac049-B217","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12902-020-00571-y","article-title":"Neutrophil: lymphocyte ratio is positively associated with subclinical diabetic cardiomyopathy","volume":"20","author":"Huang","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"2023050214505370200_cvac049-B218","doi-asserted-by":"crossref","first-page":"e123047","DOI":"10.1172\/jci.insight.123047","article-title":"Glucose metabolism controls disease-specific signatures of macrophage effector functions","volume":"3","author":"Watanabe","year":"2018","journal-title":"JCI Insight"},{"key":"2023050214505370200_cvac049-B219","doi-asserted-by":"crossref","first-page":"e9539","DOI":"10.1371\/journal.pone.0009539","article-title":"Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice","volume":"5","author":"Khanna","year":"2010","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B220","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1189\/jlb.70.3.395","article-title":"Agonist-dependent failure of neutrophil function in diabetes correlates with extent of hyperglycemia","volume":"70","author":"McManus","year":"2001","journal-title":"J Leukoc Biol"},{"key":"2023050214505370200_cvac049-B221","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jocit.2018.02.001","article-title":"Neutrophil secretion modulates neutrophil and monocyte functions during hyperglucose and\/or hyperinsulin conditions in vitro","volume":"4","author":"Neethi Raj","year":"2018","journal-title":"J Cell Immunother"},{"key":"2023050214505370200_cvac049-B222","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1677\/joe.1.06438","article-title":"Diabetes causes marked changes in function and metabolism of rat neutrophils","volume":"188","author":"Alba-Loureiro","year":"2006","journal-title":"J Endocrinol"},{"key":"2023050214505370200_cvac049-B223","first-page":"9","article-title":"Nonspecific immunity in diabetes: hyperglycemia decreases phagocytic activity of leukocytes in diabetic patients","volume":"49","author":"Jakeli\u0107","year":"1995","journal-title":"Med Arh"},{"key":"2023050214505370200_cvac049-B224","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.immuni.2014.01.006","article-title":"Transcriptome-based network analysis reveals a spectrum model of human macrophage activation","volume":"40","author":"Xue","year":"2014","journal-title":"Immunity"},{"key":"2023050214505370200_cvac049-B225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/ni.3710","article-title":"Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk","volume":"18","author":"Piccolo","year":"2017","journal-title":"Nat Immunol"},{"key":"2023050214505370200_cvac049-B226","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.imbio.2017.02.006","article-title":"Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing","volume":"222","author":"Lurier","year":"2017","journal-title":"Immunobiology"},{"key":"2023050214505370200_cvac049-B227","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2174\/1381612825666190319120132","article-title":"Transcriptional characteristics of activated macrophages","volume":"25","author":"Glanz","year":"2019","journal-title":"Curr Pharm Des"},{"key":"2023050214505370200_cvac049-B228","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lfs.2014.09.015","article-title":"The heterogenic properties of monocytes\/macrophages and neutrophils in inflammatory response in diabetes","volume":"116","author":"Rao","year":"2014","journal-title":"Life Sci"},{"key":"2023050214505370200_cvac049-B229","doi-asserted-by":"crossref","first-page":"118989","DOI":"10.1016\/j.lfs.2020.118989","article-title":"The effect of miR-471-3p on macrophage polarization in the development of diabetic cardiomyopathy","volume":"268","author":"Liu","year":"2021","journal-title":"Life Sci"},{"key":"2023050214505370200_cvac049-B230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12967-019-1999-8","article-title":"Mesenchymal stem cells promote type 2 macrophage polarization to ameliorate the myocardial injury caused by diabetic cardiomyopathy","volume":"17","author":"Jin","year":"2019","journal-title":"J Transl Med"},{"key":"2023050214505370200_cvac049-B231","doi-asserted-by":"crossref","first-page":"e0120739","DOI":"10.1371\/journal.pone.0120739","article-title":"Fibroblast growth factor-9 enhances M2 macrophage differentiation and attenuates adverse cardiac remodeling in the infarcted diabetic heart","volume":"10","author":"Singla","year":"2015","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B232","doi-asserted-by":"crossref","first-page":"H762","DOI":"10.1152\/ajpheart.00367.2014","article-title":"BMP-7 attenuates adverse cardiac remodeling mediated through M2 macrophages in prediabetic cardiomyopathy","volume":"307","author":"Urbina","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023050214505370200_cvac049-B233","doi-asserted-by":"crossref","first-page":"E715","DOI":"10.1073\/pnas.1111600109","article-title":"Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1","volume":"109","author":"Kanter","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023050214505370200_cvac049-B234","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/CIRCRESAHA.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: novel roles of immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton","year":"2020","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B235","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/HYPERTENSIONAHA.114.04737","article-title":"Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet","volume":"65","author":"Jia","year":"2015","journal-title":"Hypertension"},{"key":"2023050214505370200_cvac049-B236","doi-asserted-by":"crossref","first-page":"367245","DOI":"10.1155\/2013\/367245","article-title":"Role of mitogen-activated protein kinase pathways in multifactorial adverse cardiac remodeling associated with metabolic syndrome","volume":"2013","author":"Asrih","year":"2013","journal-title":"Mediators Inflamm"},{"key":"2023050214505370200_cvac049-B237","doi-asserted-by":"crossref","first-page":"36207","DOI":"10.1038\/srep36207","article-title":"MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes","volume":"6","author":"Babu S","year":"2016","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B238","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00109-011-0816-5","article-title":"The imbalance of Th17\/Th1\/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications","volume":"90","author":"Zeng","year":"2012","journal-title":"J Mol Med (Berl)"},{"key":"2023050214505370200_cvac049-B239","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.humimm.2014.02.007","article-title":"The alteration of Th1\/Th2\/Th17\/Treg paradigm in patients with type 2 diabetes mellitus: relationship with diabetic nephropathy","volume":"75","author":"Zhang","year":"2014","journal-title":"Hum Immunol"},{"key":"2023050214505370200_cvac049-B240","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/CIRCHEARTFAILURE.115.002225","article-title":"Left ventricular t-cell recruitment contributes to the pathogenesis of heart failure","volume":"8","author":"Nevers","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2023050214505370200_cvac049-B241","doi-asserted-by":"crossref","first-page":"e85770","DOI":"10.1371\/journal.pone.0085770","article-title":"Elevated peripheral frequencies of Th22 cells: a novel potent participant in obesity and type 2 diabetes","volume":"9","author":"Zhao","year":"2014","journal-title":"PLoS One"},{"key":"2023050214505370200_cvac049-B242","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-13-1","article-title":"Increased Th1 and suppressed Th2 serum cytokine levels in subjects with diabetic coronary artery disease","volume":"13","author":"Madhumitha","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B243","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1126\/science.1201475","article-title":"Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis","volume":"332","author":"Wu","year":"2011","journal-title":"Science"},{"key":"2023050214505370200_cvac049-B244","doi-asserted-by":"crossref","first-page":"315ra189","DOI":"10.1126\/scitranslmed.aad4134","article-title":"Type 1 diabetes immunotherapy using polyclonal regulatory T cells","volume":"7","author":"Bluestone","year":"2015","journal-title":"Sci Transl Med"},{"key":"2023050214505370200_cvac049-B245","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-3083.2010.02374.x","article-title":"The Treg\/Th17 imbalance in patients with idiopathic dilated cardiomyopathy","volume":"71","author":"Li","year":"2010","journal-title":"Scand J Immunol"},{"key":"2023050214505370200_cvac049-B246","doi-asserted-by":"crossref","first-page":"14414","DOI":"10.1074\/jbc.M809757200","article-title":"WISP1, a pro-mitogenic, pro-survival factor, mediates tumor necrosis factor-alpha (TNF-alpha)-stimulated cardiac fibroblast proliferation but inhibits TNF-alpha-induced cardiomyocyte death","volume":"284","author":"Venkatachalam","year":"2009","journal-title":"J Biol Chem"},{"key":"2023050214505370200_cvac049-B247","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","article-title":"Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting Akt and JNK pathways","volume":"105","author":"Honsho","year":"2009","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B248","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/wrr.12946","article-title":"Monocyte and macrophage derived myofibroblasts: is it fate? A review of the current evidence","volume":"29","author":"Vierhout","year":"2021","journal-title":"Wound Repair Regen"},{"key":"2023050214505370200_cvac049-B249","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.jacc.2019.10.036","article-title":"Transition of macrophages to fibroblast-like cells in healing myocardial infarction","volume":"74","author":"Haider","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2023050214505370200_cvac049-B250","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.3390\/cells9041051","article-title":"Intraglomerular monocyte\/macrophage infiltration and macrophage-myofibroblast transition during diabetic nephropathy is regulated by the A2B adenosine receptor","volume":"9","author":"Torres","year":"2020","journal-title":"Cells"},{"key":"2023050214505370200_cvac049-B251","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/s41467-018-03208-w","article-title":"Direct conversion of injury-site myeloid cells to fibroblast-like cells of granulation tissue","volume":"9","author":"Sinha","year":"2018","journal-title":"Nat Commun"},{"key":"2023050214505370200_cvac049-B252","doi-asserted-by":"crossref","first-page":"27066","DOI":"10.3402\/jev.v4.27066","article-title":"Biological properties of extracellular vesicles and their physiological functions","volume":"4","author":"Y\u00e1\u00f1ez-M\u00f3","year":"2015","journal-title":"J Extracell Vesicles"},{"key":"2023050214505370200_cvac049-B253","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41420-020-00305-y","article-title":"Extracellular vesicles in cardiovascular diseases","volume":"6","author":"Fu","year":"2020","journal-title":"Cell Death Discov"},{"key":"2023050214505370200_cvac049-B254","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/978-981-10-4397-0_8","article-title":"Pathological effects of exosomes in mediating diabetic cardiomyopathy","volume":"998","author":"Salem","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"2023050214505370200_cvac049-B255","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fcvm.2017.00071","article-title":"Extracellular vesicles as protagonists of diabetic cardiovascular pathology","volume":"4","author":"Gustafson","year":"2017","journal-title":"Front Cardiovasc Med"},{"key":"2023050214505370200_cvac049-B256","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2337\/db20-0199","article-title":"CD31+ extracellular vesicles from patients with type 2 diabetes shuttle a miRNA signature associated with cardiovascular complications","volume":"70","author":"Prattichizzo","year":"2021","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B257","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2009.06.037","article-title":"Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus","volume":"208","author":"Feng","year":"2010","journal-title":"Atherosclerosis"},{"key":"2023050214505370200_cvac049-B258","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.jacc.2005.02.047","article-title":"Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease","volume":"45","author":"Koga","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2023050214505370200_cvac049-B259","doi-asserted-by":"crossref","first-page":"E2271","DOI":"10.1210\/jc.2012-1996","article-title":"Circulating miRNA profiles in patients with metabolic syndrome","volume":"97","author":"Karolina","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"2023050214505370200_cvac049-B260","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12933-016-0367-8","article-title":"Vascular endothelial microparticles-incorporated microRNAs are altered in patients with diabetes mellitus","volume":"15","author":"Jansen","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B261","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yjmcc.2014.05.001","article-title":"Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells","volume":"74","author":"Wang","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"2023050214505370200_cvac049-B262","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/CIRCRESAHA.110.226357","article-title":"Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes","volume":"107","author":"Zampetaki","year":"2010","journal-title":"Circ Res"},{"key":"2023050214505370200_cvac049-B263","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1161\/CIRCULATIONAHA.113.001720","article-title":"Endothelial microparticle-mediated transfer of MicroRNA-126 promotes vascular endothelial cell repair via SPRED1 and is abrogated in glucose-damaged endothelial microparticles","volume":"128","author":"Jansen","year":"2013","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B264","doi-asserted-by":"crossref","first-page":"E828","DOI":"10.1152\/ajpendo.00056.2016","article-title":"The effects of microvesicles on endothelial progenitor cells are compromised in type 2 diabetic patients via downregulation of the miR-126\/VEGFR2 pathway","volume":"310","author":"Wu","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2023050214505370200_cvac049-B265","doi-asserted-by":"crossref","first-page":"8024","DOI":"10.1038\/ncomms9024","article-title":"p75NTR-dependent activation of NF-\u03baB regulates microRNA-503 transcription and pericyte\u2013endothelial crosstalk in diabetes after limb ischaemia","volume":"6","author":"Caporali","year":"2015","journal-title":"Nat Commun"},{"key":"2023050214505370200_cvac049-B266","first-page":"E6927","article-title":"Serum exosomes mediate delivery of arginase 1 as a novel mechanism for endothelial dysfunction in diabetes","volume":"115","author":"Zhang","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023050214505370200_cvac049-B267","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J Clin Invest"},{"key":"2023050214505370200_cvac049-B268","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12933-021-01245-2","article-title":"MicroRNAs and long non-coding RNAs in the pathophysiological processes of diabetic cardiomyopathy: emerging biomarkers and potential therapeutics","volume":"20","author":"Jakubik","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B269","doi-asserted-by":"crossref","first-page":"655598","DOI":"10.3389\/fcvm.2021.655598","article-title":"Long non-coding RNA: a key regulator in the pathogenesis of diabetic cardiomyopathy","volume":"8","author":"Guo","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"2023050214505370200_cvac049-B270","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.1111\/jcmm.14510","article-title":"Non-coding RNA involvement in the pathogenesis of diabetic cardiomyopathy","volume":"23","author":"Zhang","year":"2019","journal-title":"J Cell Mol Med"},{"key":"2023050214505370200_cvac049-B271","doi-asserted-by":"crossref","first-page":"36340","DOI":"10.1038\/srep36340","article-title":"lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B272","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41419-018-1029-4","article-title":"Silencing long non-coding RNA Kcnq1ot1 alleviates pyroptosis and fibrosis in diabetic cardiomyopathy","volume":"9","author":"Yang","year":"2018","journal-title":"Cell Death Dis"},{"key":"2023050214505370200_cvac049-B273","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1159\/000494576","article-title":"LncRNA KCNQ1OT1 mediates pyroptosis in diabetic cardiomyopathy","volume":"50","author":"Yang","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2023050214505370200_cvac049-B274","doi-asserted-by":"crossref","first-page":"665811","DOI":"10.3389\/fendo.2021.665811","article-title":"Emerging role of long non-coding RNAs in diabetic vascular complications","volume":"12","author":"Tanwar","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023050214505370200_cvac049-B275","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.2337\/db14-0298","article-title":"Regulation of inflammatory phenotype in macrophages by a diabetes-induced long noncoding RNA","volume":"63","author":"Reddy","year":"2014","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B276","first-page":"e143289","article-title":"lncRNA DRAIR is downregulated in diabetic monocytes and modulates the inflammatory phenotype via epigenetic mechanisms","volume":"6","author":"Reddy","year":"2021","journal-title":"JCI Insight"},{"key":"2023050214505370200_cvac049-B277","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1002\/jcp.27296","article-title":"LncRNA HOTAIR functions as a competing endogenous RNA to upregulate SIRT1 by sponging miR-34a in diabetic cardiomyopathy","volume":"234","author":"Gao","year":"2019","journal-title":"J Cell Physiol"},{"key":"2023050214505370200_cvac049-B278","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.ijcard.2015.10.019","article-title":"Involvement of long noncoding RNA MALAT1 in the pathogenesis of diabetic cardiomyopathy","volume":"202","author":"Zhang","year":"2016","journal-title":"Int J Cardiol"},{"key":"2023050214505370200_cvac049-B279","doi-asserted-by":"crossref","first-page":"e2929","DOI":"10.1038\/cddis.2017.321","article-title":"lncRNA MIAT functions as a competing endogenous RNA to upregulate DAPK2 by sponging miR-22-3p in diabetic cardiomyopathy","volume":"8","author":"Zhou","year":"2017","journal-title":"Cell Death Dis"},{"key":"2023050214505370200_cvac049-B280","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3389\/fcell.2020.00243","article-title":"LncRNA-MIAT-mediated miR-214-3p silencing is responsible for IL-17 production and cardiac fibrosis in diabetic cardiomyopathy","volume":"8","author":"Qi","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"2023050214505370200_cvac049-B281","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/febs.14780","article-title":"Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-Crnde negative feedback in diabetic cardiomyopathy","volume":"286","author":"Zheng","year":"2019","journal-title":"FEBS J"},{"key":"2023050214505370200_cvac049-B282","first-page":"718","article-title":"Inhibition of long non-coding RNA TUG1 protects against diabetic cardiomyopathy induced diastolic dysfunction by regulating miR-499-5p","volume":"12","author":"Zhao","year":"2020","journal-title":"Am J Transl Res"},{"key":"2023050214505370200_cvac049-B283","doi-asserted-by":"crossref","first-page":"40342","DOI":"10.1038\/srep40342","article-title":"CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts","volume":"7","author":"Tang","year":"2017","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B284","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbrc.2017.04.044","article-title":"A novel identified circular RNA, circRNA_010567, promotes myocardial fibrosis via suppressing miR-141 by targeting TGF-\u03b21","volume":"487","author":"Zhou","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"2023050214505370200_cvac049-B285","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1038\/s41598-021-82345-7","article-title":"Identification and analysis of circulating long non-coding RNAs with high significance in diabetic cardiomyopathy","volume":"11","author":"Pant","year":"2021","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B286","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/14017431.2018.1546896","article-title":"LncRNA TINCR is downregulated in diabetic cardiomyopathy and relates to cardiomyocyte apoptosis","volume":"52","author":"Chen","year":"2018","journal-title":"Scand Cardiovasc J"},{"key":"2023050214505370200_cvac049-B287","first-page":"1221","article-title":"LncRNA NKILA was upregulated in diabetic cardiomyopathy with early prediction values","volume":"18","author":"Li","year":"2019","journal-title":"Exp Ther Med"},{"key":"2023050214505370200_cvac049-B288","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1530\/JOE-15-0201","article-title":"Microvesicles and exosomes: new players in metabolic and cardiovascular disease","volume":"228","author":"Lawson","year":"2016","journal-title":"J Endocrinol"},{"key":"2023050214505370200_cvac049-B289","doi-asserted-by":"crossref","first-page":"e3107","DOI":"10.1002\/dmrr.3107","article-title":"Exosomes and diabetes","volume":"35","author":"Casta\u00f1o","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"2023050214505370200_cvac049-B290","doi-asserted-by":"crossref","first-page":"e007442","DOI":"10.1161\/JAHA.117.007442","article-title":"Adipose-derived exosomes exert proatherogenic effects by regulating macrophage foam cell formation and polarization","volume":"7","author":"Xie","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2023050214505370200_cvac049-B291","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1159\/000492252","article-title":"Adipocyte-derived exosomes carrying sonic hedgehog mediate M1 macrophage polarization-induced insulin resistance via ptch and PI3K pathways","volume":"48","author":"Song","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"2023050214505370200_cvac049-B292","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","article-title":"Adipose tissue macrophage-derived exosomal miRNAs can modulate in vivo and in vitro insulin sensitivity","volume":"171","author":"Ying","year":"2017","journal-title":"Cell"},{"key":"2023050214505370200_cvac049-B293","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12265-018-9825-x","article-title":"The exosome: a new player in diabetic cardiomyopathy","volume":"12","author":"Tao","year":"2019","journal-title":"J Cardiovasc Transl Res"},{"key":"2023050214505370200_cvac049-B294","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.2337\/db15-1563","article-title":"Hsp20-mediated activation of exosome biogenesis in cardiomyocytes improves cardiac function and angiogenesis in diabetic mice","volume":"65","author":"Wang","year":"2016","journal-title":"Diabetes"},{"key":"2023050214505370200_cvac049-B295","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1242\/dmm.001941","article-title":"Rodent models of diabetic cardiomyopathy","volume":"2","author":"Bugger","year":"2009","journal-title":"Dis Model Mech"},{"key":"2023050214505370200_cvac049-B296","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","article-title":"Of mice and men: models and mechanisms of diabetic cardiomyopathy","volume":"114","author":"Riehle","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"2023050214505370200_cvac049-B297","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fphys.2019.01395","article-title":"Characterising an alternative murine model of diabetic cardiomyopathy","volume":"10","author":"Tate","year":"2019","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B298","doi-asserted-by":"crossref","first-page":"2902351","DOI":"10.1155\/2016\/2902351","article-title":"An overview of murine high fat diet as a model for type 2 diabetes mellitus","volume":"2016","author":"Heydemann","year":"2016","journal-title":"J Diabetes Res"},{"key":"2023050214505370200_cvac049-B299","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1038\/s41467-020-15978-3","article-title":"MD2 activation by direct AGE interaction drives inflammatory diabetic cardiomyopathy","volume":"11","author":"Wang","year":"2020","journal-title":"Nat Commun"},{"key":"2023050214505370200_cvac049-B300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1677\/joe.1.06241","article-title":"Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob\/ob obese mice","volume":"188","author":"Dong","year":"2006","journal-title":"J Endocrinol"},{"key":"2023050214505370200_cvac049-B301","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.2147\/DDDT.S258459","article-title":"New benzofuran N-acylhydrazone reduces cardiovascular dysfunction in obese rats by blocking TNF-alpha synthesis","volume":"14","author":"Costa","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"2023050214505370200_cvac049-B302","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1093\/ilar.47.3.186","article-title":"Animal models of type 2 diabetes: clinical presentation and pathophysiological relevance to the human condition","volume":"47","author":"Cefalu","year":"2006","journal-title":"ILAR J"},{"key":"2023050214505370200_cvac049-B303","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fcvm.2018.00120","article-title":"Genetic and tissue engineering approaches to modeling the mechanics of human heart failure for drug discovery","volume":"5","author":"Greenberg","year":"2018","journal-title":"Front Cardiovasc Med"},{"key":"2023050214505370200_cvac049-B304","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"2023050214505370200_cvac049-B305","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"2023050214505370200_cvac049-B306","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3389\/fphar.2019.00934","article-title":"Considerations for an in vitro, cell-based testing platform for detection of drug-induced inotropic effects in early drug development. Part 2: designing and fabricating microsystems for assaying cardiac contractility with physiological relevance using human iPSC-cardiomyocytes","volume":"10","author":"Ribeiro","year":"2019","journal-title":"Front Pharmacol"},{"key":"2023050214505370200_cvac049-B307","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.3390\/ijms21124354","article-title":"Modeling cardiac disease mechanisms using induced pluripotent stem cell-derived cardiomyocytes: progress, promises and challenges","volume":"21","author":"Parrotta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B308","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yjmcc.2020.03.016","article-title":"Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGF\u03b2 signaling in type 2 diabetes mellitus","volume":"142","author":"Tang","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"2023050214505370200_cvac049-B309","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.stem.2019.03.009","article-title":"Drug screening in human PSC-cardiac organoids identifies pro-proliferative compounds acting via the mevalonate pathway","volume":"24","author":"Mills","year":"2019","journal-title":"Cell Stem Cell"},{"key":"2023050214505370200_cvac049-B310","doi-asserted-by":"crossref","first-page":"24637","DOI":"10.1038\/srep24637","article-title":"Induction of human iPSC-derived cardiomyocyte proliferation revealed by combinatorial screening in high density microbioreactor arrays","volume":"6","author":"Titmarsh","year":"2016","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B311","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"2023050214505370200_cvac049-B312","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"2023050214505370200_cvac049-B313","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2217\/rme.15.1","article-title":"Development of a global network of induced pluripotent stem cell haplobanks","volume":"10","author":"Wilmut","year":"2015","journal-title":"Regen Med"},{"key":"2023050214505370200_cvac049-B314","doi-asserted-by":"crossref","first-page":"102036","DOI":"10.1016\/j.scr.2020.102036","article-title":"The global alliance for iPSC therapies (GAiT)","volume":"49","author":"Sullivan","year":"2020","journal-title":"Stem Cell Res"},{"key":"2023050214505370200_cvac049-B315","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1002\/stem.2865","article-title":"Repurposing the cord blood bank for haplobanking of HLA-homozygous iPSCs and their usefulness to multiple populations","volume":"36","author":"Lee","year":"2018","journal-title":"Stem Cells"},{"key":"2023050214505370200_cvac049-B316","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.celrep.2014.09.055","article-title":"Disease modeling and phenotypic drug screening for diabetic cardiomyopathy using human induced pluripotent stem cells","volume":"9","author":"Drawnel","year":"2014","journal-title":"Cell Rep"},{"key":"2023050214505370200_cvac049-B317","doi-asserted-by":"crossref","first-page":"14872","DOI":"10.1038\/s41598-018-33293-2","article-title":"Empagliflozin ammeliorates high glucose induced-cardiac dysfuntion in human iPSC-derived cardiomyocytes","volume":"8","author":"Ng","year":"2018","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B318","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12015-018-9858-1","article-title":"Diabetic cardiomyopathy modelling using induced pluripotent stem cell derived cardiomyocytes: recent advances and emerging models","volume":"15","author":"Gran\u00e9li","year":"2019","journal-title":"Stem Cell Rev Rep"},{"key":"2023050214505370200_cvac049-B319","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1213\/ANE.0000000000001254","article-title":"High glucose attenuates anesthetic cardioprotection in stem-cell-derived cardiomyocytes: the role of reactive oxygen species and mitochondrial fission","volume":"122","author":"Canfield","year":"2016","journal-title":"Anesth Analg"},{"key":"2023050214505370200_cvac049-B320","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/cvr\/cvab043","article-title":"Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart","volume":"118","author":"Prakoso","year":"2022;","journal-title":"Cardiovasc Res"},{"key":"2023050214505370200_cvac049-B321","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.freeradbiomed.2021.02.016","article-title":"The role of ceramide accumulation in human induced pluripotent stem cell-derived cardiomyocytes on mitochondrial oxidative stress and mitophagy","volume":"167","author":"Bekhite","year":"2021","journal-title":"Free Radic Biol Med"},{"key":"2023050214505370200_cvac049-B322","doi-asserted-by":"crossref","first-page":"667252","DOI":"10.3389\/fcell.2021.667252","article-title":"Diabetic endothelial cells differentiated from patient iPSCs show dysregulated glycine homeostasis and senescence associated phenotypes","volume":"9","author":"Su","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2023050214505370200_cvac049-B323","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.stemcr.2019.01.017","article-title":"Calpain inhibition restores autophagy and prevents mitochondrial fragmentation in a human iPSC model of diabetic endotheliopathy","volume":"12","author":"Ong","year":"2019","journal-title":"Stem Cell Rep"},{"key":"2023050214505370200_cvac049-B324","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00246-017-1698-2","article-title":"Effect of glucose on 3D cardiac microtissues derived from human induced pluripotent stem cells","volume":"38","author":"Balistreri","year":"2017","journal-title":"Pediatr Cardiol"},{"key":"2023050214505370200_cvac049-B325","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1038\/s41467-021-25329-5","article-title":"Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease","volume":"12","author":"Lewis-Israeli","year":"2021","journal-title":"Nat Commun"},{"key":"2023050214505370200_cvac049-B326","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41586-018-0858-8","article-title":"Human blood vessel organoids as a model of diabetic vasculopathy","volume":"565","author":"Wimmer","year":"2019","journal-title":"Nature"},{"key":"2023050214505370200_cvac049-B327","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11886-017-0842-1","article-title":"Untangling the biology of genetic cardiomyopathies with pluripotent stem cell disease models","volume":"19","author":"Buikema","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"2023050214505370200_cvac049-B328","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/cvr\/cvy208","article-title":"Modelling inherited cardiac disease using human induced pluripotent stem cell-derived cardiomyocytes: progress, pitfalls, and potential","volume":"114","author":"van Mil","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2023050214505370200_cvac049-B329","doi-asserted-by":"crossref","first-page":"384","DOI":"10.3389\/fphys.2020.00384","article-title":"Beyond family: modeling non-hereditary heart diseases with human pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Martewicz","year":"2020","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B330","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/cpt.1286","article-title":"Human cardiac organoids for disease modeling","volume":"105","author":"Nugraha","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"2023050214505370200_cvac049-B331","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","article-title":"Cardioids reveal self-organizing principles of human cardiogenesis","volume":"184","author":"Hofbauer","year":"2021","journal-title":"Cell"},{"key":"2023050214505370200_cvac049-B332","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.stemcr.2021.03.013","article-title":"Engineering spatial-organized cardiac organoids for developmental toxicity testing","volume":"16","author":"Hoang","year":"2021","journal-title":"Stem Cell Rep"},{"key":"2023050214505370200_cvac049-B333","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1038\/s41596-021-00497-2","article-title":"Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells","volume":"16","author":"Campostrini","year":"2021","journal-title":"Nat Protoc"},{"key":"2023050214505370200_cvac049-B334","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1038\/s41467-020-18031-5","article-title":"In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix","volume":"11","author":"Lee","year":"2020","journal-title":"Nat Commun"},{"key":"2023050214505370200_cvac049-B335","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/s41587-021-00815-9","article-title":"Human heart-forming organoids recapitulate early heart and foregut development","volume":"39","author":"Drakhlis","year":"2021","journal-title":"Nat Biotechnol"},{"key":"2023050214505370200_cvac049-B336","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nprot.2018.006","article-title":"Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells","volume":"13","author":"Hoang","year":"2018","journal-title":"Nat Protoc"},{"key":"2023050214505370200_cvac049-B337","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.3390\/ijms22031479","article-title":"Engineering and assessing cardiac tissue complexity","volume":"22","author":"Tadevosyan","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B338","doi-asserted-by":"crossref","first-page":"H927","DOI":"10.1152\/ajpheart.00546.2020","article-title":"Functional coculture of sympathetic neurons and cardiomyocytes derived from human-induced pluripotent stem cells","volume":"319","author":"Winbo","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023050214505370200_cvac049-B339","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.stem.2016.05.002","article-title":"Functional coupling with cardiac muscle promotes maturation of hPSC-derived sympathetic neurons","volume":"19","author":"Oh","year":"2016","journal-title":"Cell Stem Cell"},{"key":"2023050214505370200_cvac049-B340","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/bioengineering5030049","article-title":"Towards multi-organoid systems for drug screening applications","volume":"5","author":"Miranda","year":"2018","journal-title":"Bioengineering (Basel)"},{"key":"2023050214505370200_cvac049-B341","doi-asserted-by":"crossref","first-page":"dev156125","DOI":"10.1242\/dev.156125","article-title":"Developmentally inspired human \u2018organs on chips\u2019","volume":"145","author":"Ingber","year":"2018","journal-title":"Development"},{"key":"2023050214505370200_cvac049-B342","doi-asserted-by":"crossref","first-page":"536","DOI":"10.3390\/mi9100536","article-title":"Organs-on-a-chip module: a review from the development and applications perspective","volume":"9","author":"Sosa-Hern\u00e1ndez","year":"2018","journal-title":"Micromachines (Basel)"},{"key":"2023050214505370200_cvac049-B343","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1001\/jama.2014.3321","article-title":"Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial","volume":"311","author":"Lincoff","year":"2014","journal-title":"JAMA"},{"key":"2023050214505370200_cvac049-B344","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"key":"2023050214505370200_cvac049-B345","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jchf.2014.04.005","article-title":"Sitagliptin use in patients with diabetes and heart failure: a population-based retrospective cohort study","volume":"2","author":"Weir","year":"2014","journal-title":"JACC Heart Fail"},{"key":"2023050214505370200_cvac049-B346","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/jama.290.1.81","article-title":"Metformin and thiazolidinedione use in Medicare patients with heart failure","volume":"290","author":"Masoudi","year":"2003","journal-title":"JAMA"},{"key":"2023050214505370200_cvac049-B347","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1161\/CIRCHEARTFAILURE.112.000162","article-title":"Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients","volume":"6","author":"Eurich","year":"2013","journal-title":"Circ Heart Fail"},{"key":"2023050214505370200_cvac049-B348","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.3390\/ijms19102869","article-title":"Metabolic effects of metformin in the failing heart","volume":"19","author":"Dziubak","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2023050214505370200_cvac049-B349","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1038\/s41467-021-22130-2","article-title":"Loss of bone morphogenetic protein-binding endothelial regulator causes insulin resistance","volume":"12","author":"Mao","year":"2021","journal-title":"Nat Commun"},{"key":"2023050214505370200_cvac049-B350","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"2023050214505370200_cvac049-B351","doi-asserted-by":"crossref","first-page":"19351","DOI":"10.1038\/s41598-019-55524-w","article-title":"Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: a meta-analysis","volume":"9","author":"Castellana","year":"2019","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B352","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2023050214505370200_cvac049-B353","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"2023050214505370200_cvac049-B354","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"2023050214505370200_cvac049-B355","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.118.035759","article-title":"Improvement in cardiovascular outcomes with empagliflozin is independent of glycemic control","volume":"138","author":"Inzucchi","year":"2018","journal-title":"Circulation"},{"key":"2023050214505370200_cvac049-B356","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"2023050214505370200_cvac049-B357","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s13300-010-0006-4","article-title":"Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members","volume":"1","author":"Chen","year":"2010","journal-title":"Diabetes Ther"},{"key":"2023050214505370200_cvac049-B358","doi-asserted-by":"crossref","first-page":"41166","DOI":"10.1038\/srep41166","article-title":"Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart","volume":"7","author":"Van Steenbergen","year":"2017","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B359","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11897-021-00529-8","article-title":"SGLT2 inhibitors and their mode of action in heart failure-has the mystery been unravelled?","volume":"18","author":"Pabel","year":"2021","journal-title":"Curr Heart Fail Rep"},{"key":"2023050214505370200_cvac049-B360","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ijcard.2017.05.032","article-title":"Sodium-dependent glucose transporters (SGLT) in human ischemic heart: a new potential pharmacological target","volume":"243","author":"Di Franco","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023050214505370200_cvac049-B361","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/MSMBR.907775","article-title":"Phlorizin exerts direct protective effects on Palmitic Acid (PA)-induced endothelial dysfunction by activating the PI3K\/AKT\/eNOS signaling pathway and increasing the levels of Nitric Oxide (NO)","volume":"24","author":"Li","year":"2018","journal-title":"Med Sci Monit Basic Res"},{"key":"2023050214505370200_cvac049-B362","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.vph.2018.06.006","article-title":"Hyperglycaemic impairment of PAR2-mediated vasodilation: prevention by inhibition of aortic endothelial sodium-glucose-co-transporter-2 and minimizing oxidative stress","volume":"109","author":"El-Daly","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"2023050214505370200_cvac049-B363","doi-asserted-by":"crossref","first-page":"109825","DOI":"10.1016\/j.cellsig.2020.109825","article-title":"The SGLT2 inhibitor empagliflozin attenuates interleukin-17A-induced human aortic smooth muscle cell proliferation and migration by targeting TRAF3IP2\/ROS\/NLRP3\/Caspase-1-dependent IL-1\u03b2 and IL-18 secretion","volume":"77","author":"Sukhanov","year":"2021","journal-title":"Cell Signal"},{"key":"2023050214505370200_cvac049-B364","first-page":"100640","article-title":"Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice","volume":"18","author":"Takahashi","year":"2019","journal-title":"Biochem Biophys Rep"},{"key":"2023050214505370200_cvac049-B365","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/cvr\/cvx186","article-title":"Effects of dapagliflozin on human epicardial adipose tissue: modulation of insulin resistance, inflammatory chemokine production, and differentiation ability","volume":"114","author":"D\u00edaz-Rodr\u00edguez","year":"2018","journal-title":"Cardiovasc Res"},{"key":"2023050214505370200_cvac049-B366","doi-asserted-by":"crossref","first-page":"112169","DOI":"10.1016\/j.biopha.2021.112169","article-title":"Effects of SGLT2 inhibitors on ion homeostasis and oxidative stress associated mechanisms in heart failure","volume":"143","author":"Gager","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"2023050214505370200_cvac049-B367","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2169\/internalmedicine.0701-17","article-title":"The SGLT2 inhibitor dapagliflozin significantly improves the peripheral microvascular endothelial function in patients with uncontrolled type 2 diabetes mellitus","volume":"57","author":"Sugiyama","year":"2018","journal-title":"Intern Med"},{"key":"2023050214505370200_cvac049-B368","article-title":"Switch to SGLT2 inhibitors and improved endothelial function in diabetic patients with chronic heart failure","author":"Correale","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"2023050214505370200_cvac049-B369","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fcvm.2016.00043","article-title":"Glycemic control with ipragliflozin, a novel selective SGLT2 inhibitor, ameliorated endothelial dysfunction in streptozotocin-induced diabetic mouse","volume":"3","author":"Salim","year":"2016","journal-title":"Front Cardiovasc Med"},{"key":"2023050214505370200_cvac049-B370","doi-asserted-by":"crossref","first-page":"13700","DOI":"10.1038\/s41598-021-93156-1","article-title":"Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial \u03b11AMPK","volume":"11","author":"Ang\u00e9","year":"2021","journal-title":"Sci Rep"},{"key":"2023050214505370200_cvac049-B371","doi-asserted-by":"crossref","first-page":"683594","DOI":"10.3389\/fcell.2021.683594","article-title":"EndMT regulation by small RNAs in diabetes-associated fibrotic conditions: potential link with oxidative stress","volume":"9","author":"Giordo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"2023050214505370200_cvac049-B372","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J Cell Mol Med"},{"key":"2023050214505370200_cvac049-B373","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.freeradbiomed.2017.01.035","article-title":"Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts","volume":"104","author":"Lee","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"2023050214505370200_cvac049-B374","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.3390\/jcm8111814","article-title":"The SGLT2 inhibitor empagliflozin ameliorates the inflammatory profile in type 2 diabetic patients and promotes an antioxidant response in leukocytes","volume":"8","author":"Iannantuoni","year":"2019","journal-title":"J Clin Med"},{"key":"2023050214505370200_cvac049-B375","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur Heart J"},{"key":"2023050214505370200_cvac049-B376","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12933-021-01293-8","article-title":"Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis","volume":"20","author":"Li","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2023050214505370200_cvac049-B377","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3389\/fphys.2012.00110","article-title":"Sympathetic responses to central hypovolemia: new insights from microneurographic recordings","volume":"3","author":"Ryan","year":"2012","journal-title":"Front Physiol"},{"key":"2023050214505370200_cvac049-B378","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jash.2017.07.005","article-title":"The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus","volume":"11","author":"Jordan","year":"2017","journal-title":"J Am Soc Hypertens"},{"key":"2023050214505370200_cvac049-B379","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11886-019-1165-1","article-title":"Effect of SGLT2 inhibitors on the sympathetic nervous system and blood pressure","volume":"21","author":"Scheen","year":"2019","journal-title":"Curr Cardiol Rep"},{"key":"2023050214505370200_cvac049-B380","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3389\/fendo.2018.00421","article-title":"The effects of sodium-glucose cotransporter 2 inhibitors on sympathetic nervous activity","volume":"9","author":"Wan","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023050214505370200_cvac049-B381","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/HJH.0000000000001434","article-title":"Role of the sympathetic nervous system in regulation of the sodium glucose cotransporter 2","volume":"35","author":"Matthews","year":"2017","journal-title":"J Hypertens"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvac049\/45052962\/cvac049.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/119\/3\/668\/50169450\/cvac049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/119\/3\/668\/50169450\/cvac049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T15:22:06Z","timestamp":1683040926000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/119\/3\/668\/6564549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,7]]},"references-count":381,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,4,7]]},"published-print":{"date-parts":[[2023,5,2]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvac049","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,3,1]]},"published":{"date-parts":[[2022,4,7]]}}}